Nagai Noriaki, Murao Takatoshi, Ito Yoshimasa
School of Pharmacy, Kinki University, Higashi-Osaka, Japan.
Yakugaku Zasshi. 2009 Dec;129(12):1515-21. doi: 10.1248/yakushi.129.1515.
Dissolution testing is a core performance test in pharmaceutical development and quality control. Generally, the HPLC method uses the analysis of dissolution testing. In this study, we attempted to improve the dissolution test by using microdialysis methods. We also investigated the comparison of the conventional HPLC dissolution method (batch-sampling method) and the improved dissolution test (microdialysis method). Histamine H(2)-receptor antagonist cimetidine tablets (200 mg), which are used clinically and of which there are also some generic examples, were selected for this comparison, and the dissolution behavior of the tablets by the two methods were found to be similar. On the other hand, standard deviation in the microdialysis method was lower than that of the batch-sampling method. In addition, the microdialysis method can omit many steps such as the filtration, collection and replenishment of sample solutions, and is also able to accomplish continuous sampling of sample solutions. These findings provide significant information that can be used in the pharmaceutical development and quality control of original and generic products.
溶出度测试是药物研发和质量控制中的一项核心性能测试。一般来说,高效液相色谱法用于溶出度测试的分析。在本研究中,我们尝试通过使用微透析方法来改进溶出度测试。我们还研究了传统的高效液相色谱溶出度方法(批量取样法)与改进后的溶出度测试(微透析法)之间的比较。选择临床上使用且有一些仿制药实例的组胺H(2)受体拮抗剂西咪替丁片(200毫克)进行此比较,发现两种方法对该片剂的溶出行为相似。另一方面,微透析法的标准偏差低于批量取样法。此外,微透析法可以省略样品溶液的过滤、收集和补充等许多步骤,并且还能够完成样品溶液的连续取样。这些发现提供了可用于原研产品和仿制药产品的药物研发和质量控制的重要信息。